SP1 and chronic myelogenous leukemia, BCR-ABL1 positive: Doxorubicin treatment up-regulates Sp1 protein and mRNA levels in the human breast adenocarcinoma MCF-7 [42] and chronic myeloid leukemic cell line K562 cells, respectively [43].